Over the last few years, Cyient stock has been plagued by revenue growth challenges and margin pressures at the company.
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., May 30, 2026 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results